Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice
- PMID: 10096549
Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice
Abstract
Germ-line mutations of the human TSC2 tumor suppressor gene cause tuberous sclerosis (TSC), a disease characterized by the development of hamartomas in various organs. In the Eker rat, however, a germ-line Tsc2 mutation gives rise to renal cell carcinomas with a complete penetrance. The molecular mechanism for this phenotypic difference between man and rat is currently unknown, and the physiological function of the TSC2/Tsc2 product (tuberin) is not fully understood. To investigate these unsolved problems, we have generated a Tsc2 mutant mouse. Tsc2 heterozygous mutant (Tsc2+/-) mice developed renal carcinomas with a complete penetrance, as seen in the Eker rat, but not the angiomyolipomas characteristic of human TSC, confirming the existence of a species-specific mechanism of tumorigenesis caused by tuberin deficiency. Unexpectedly, approximately 80% of Tsc2+/- mice also developed hepatic hemangiomas that are not observed in either TSC or the Eker rat. Tsc2 homozygous (Tsc2-/-) mutants died around embryonic day 10.5, indicating an essential function for tuberin in mouse embryonic development. Some Tsc2-/- embryos exhibited an unclosed neural tube and/or thickened myocardium. The latter is associated with increased cell density that may be a reflection of loss of a growth-suppressive function of tuberin. The mouse strain described here should provide a valuable experimental model to analyze the function of tuberin and its association with tumorigenesis.
Similar articles
-
A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice.Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8762-7. doi: 10.1073/pnas.151033798. Epub 2001 Jul 3. Proc Natl Acad Sci U S A. 2001. PMID: 11438694 Free PMC article.
-
The transcriptional profile of the kidney in Tsc2 heterozygous mutant Long Evans (Eker) rats compared to wild-type.Mutat Res. 2004 May 18;549(1-2):213-24. doi: 10.1016/j.mrfmmm.2003.12.023. Mutat Res. 2004. PMID: 15120972
-
Presence of potent transcriptional activation domains in the predisposing tuberous sclerosis (Tsc2) gene product of the Eker rat model.Cancer Res. 1996 Feb 1;56(3):429-33. Cancer Res. 1996. PMID: 8564946
-
[Cancer genetics of TSC2 gene mutant(Eker) rat model].Nihon Rinsho. 2000 Jun;58(6):1255-61. Nihon Rinsho. 2000. PMID: 10879050 Review. Japanese.
-
Multiple roles of the tuberous sclerosis complex genes.Genes Chromosomes Cancer. 2003 Dec;38(4):368-75. doi: 10.1002/gcc.10256. Genes Chromosomes Cancer. 2003. PMID: 14566857 Review.
Cited by
-
Inactivation of Tsc2 in Mesoderm-Derived Cells Causes Polycystic Kidney Lesions and Impairs Lung Alveolarization.Am J Pathol. 2016 Dec;186(12):3261-3272. doi: 10.1016/j.ajpath.2016.08.013. Epub 2016 Oct 18. Am J Pathol. 2016. PMID: 27768862 Free PMC article.
-
Nailing down a link between tuberin and renal cysts.Am J Pathol. 2003 Feb;162(2):369-71. doi: 10.1016/S0002-9440(10)63831-X. Am J Pathol. 2003. PMID: 12547695 Free PMC article. Review. No abstract available.
-
Benign tumors in TSC are amenable to treatment by GD3 CAR T cells in mice.JCI Insight. 2021 Nov 22;6(22):e152014. doi: 10.1172/jci.insight.152014. JCI Insight. 2021. PMID: 34806651 Free PMC article.
-
VHL Type 2B gene mutation moderates HIF dosage in vitro and in vivo.Oncogene. 2009 Apr 9;28(14):1694-705. doi: 10.1038/onc.2009.12. Epub 2009 Mar 2. Oncogene. 2009. PMID: 19252526 Free PMC article.
-
Human TSC2 Mutant Cells Exhibit Aberrations in Early Neurodevelopment Accompanied by Changes in the DNA Methylome.bioRxiv [Preprint]. 2024 Jun 6:2024.06.04.597443. doi: 10.1101/2024.06.04.597443. bioRxiv. 2024. PMID: 38895266 Free PMC article. Preprint.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Molecular Biology Databases